The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED)

NCT00251641 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

868

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: infliximab
DRUG: methotrexate

Sponsor

Merck Sharp & Dohme LLC